Auxilium On a Roll ...
Health Care: Drugs
Endo Pharmaceutical Holdings Inc. (ENDP: NASDAQ)
$30.87 -0.45 | -1.44%
06/04/12 - 04:00 PM ET
Company Cash Flow
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 242.06M | 287.02M | 266.34M | 261.74M |
| Operating Gains/Losses | 11.40M | 15.88M | 235.00K | -1.26M |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -107.61M | -84.66M | -62.58M | 2.97M |
| (Increase) Decrease in Inventories | -8.70M | 13.89M | 12.92M | -11.43M |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -30.27M | 30.14M | 12.07M | -17.97M |
| (Decrease) Increase In Other Current Liabilities | 205.02M | 93.35M | 34.11M | 40.56M |
| (Increase) Decrease In Other Working Capital | 43.30M | -5.05M | 2.36M | -8.18M |
| Other Non-Cash Items | 154.74M | -7.92M | -47.08M | 33.56M |
| Net Cash From Continuing Operations | 702.12M | 453.65M | 295.41M | 356.60M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 702.12M | 453.65M | 295.41M | 356.60M |
| Sale of Property, Plant & Equipment | 1.63M | 356.00K | 0.00 | 27.00K |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 231.12M | 23.75M | 447.11M |
| Purchases of Property, Plant & Equipment | -59.38M | -19.89M | -12.42M | -17.43M |
| Acquisitions | -2.38B | -1.11B | -250.36M | -15.00M |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | -134.21M |
| Other Cash from Investing Activities | -6.93M | -400.00K | -6.48M | -101.67M |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -2.37B | -896.32M | -245.51M | 178.83M |
| Issuance of Debt | 3.10B | 788.27M | 0.00 | 370.74M |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 28.95M | 20.88M | 8.04M | 52.61M |
| Repayment of Long-Term Debt | -1.21B | -508.63M | -120.72M | -108.23M |
| Repurchase of Capital Stock | -34.70M | -58.97M | 0.00 | -424.82M |
| Payment of Cash Dividends | -54.29M | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | -77.42M | -41.12M | -4.44M | -364.00K |
| Net Cash From Financing Activities | 1.75B | 200.43M | -117.13M | -110.07M |
| Effect of Exchange Rate Changes | 702.00K | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 81.41M | -242.25M | -67.23M | 425.37M |
Portfolios with ENDP
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ProLee Ainslie - Maverick Capital
- ProD.E. Shaw
- ContributorTechnical Setups for the We...
- ContributorStocks Rising On Unusual Vo...
- ContributorBreakout Stocks Of The Week...
- ProChuck Royce - Royce & Assoc...
- ProJohn Hussman
- ContributorTechnical Setups for the We...
- ProZebra Capital
Latest ENDP Headlines from TheStreet
- 7 Stocks Surging on Big Volume 05.29.12 | 01:05 pm
- Downgrades Roundup: SPX, Avon, Shutterfly 05.07.12 | 07:05 am
- Endo Pharmaceutical Holdings Inc. Stock Downgraded (ENDP) 05.03.12 | 05:05 am
- Endo Pharmaceuticals Holdings' CEO Discusses Q1 2012 Results - Earnings Call Transcript 05.01.12 | 03:05 pm
- Endo Pharmaceuticals' CEO Discusses Q4 2011 Results - Earnings Call Transcript 02.24.12 | 12:02 pm
- BioSante: A Penny Stock Still Overvalued 02.16.12 | 07:02 am
- UBS: 6 Specialty Pharma Picks to Watch 01.21.12 | 07:01 am
- Endo Pharmaceutical Holdings Inc. (ENDP): Today's Featured Health Care Winner 12.12.11 | 04:12 pm
- 7 Stocks Rising on Unusual Volume 12.12.11 | 12:12 pm
- Endo Pharmaceuticals At 2011 Credit Suisse Annual Health Care Conference Call Transcript 11.11.11 | 02:11 pm
Press Releases for ENDP
- Endo Announces Resolution Of Patent Litigation With Watson Pharmaceuticals Related To Lidoderm® - PR Newswire 05.29.12 | 07:05 am
- Endo Health Solutions Inc. To Present At Jefferies 2012 Global Healthcare Conference - PR Newswire 05.25.12 | 01:05 pm
- Endo Health Solutions Inc. To Present At The Goldman Sachs 33rd Annual Global Healthcare Conference - PR Newswire 05.25.12 | 01:05 pm
- Endo Health Solutions Inc. Announced As New Name For Endo Pharmaceuticals Holdings Inc. - PR Newswire 05.23.12 | 02:05 pm
- Endo Pharmaceuticals To Announce First Quarter 2012 Financial Results On May 1, 2012 - PR Newswire 04.17.12 | 09:04 am
- Qualitest Pharmaceuticals Receives FDA Approval For Levetiracetam Oral Solution, 100 Mg/mL - PR Newswire 04.12.12 | 04:04 pm
- Endo Announces Departure Of American Medical Systems President - PR Newswire 03.29.12 | 01:03 pm
- Endo Acquires Johnson Matthey's Oxymorphone Patent - PR Newswire 03.22.12 | 08:03 am
- BioDelivery Sciences Provides Business Review And Update In Conjunction With Filing Of Its Annual Report - PR Newswire 03.19.12 | 04:03 pm
- Endo Files Amended Citizen Petition Seeking Public FDA Resolution Of Several Safety And Efficacy Issues Prior To Approval Of A Generic Formulation Of LIDODERM® - PR Newswire 03.13.12 | 08:03 am
Partner Headlines for ENDP
- UNVEILED: Analyst Share Price Targets Wednesday - Wall St. Cheat Sheet 05.30.12 | 04:05 am
- Healthcare Biz Recap: HGSI Shareholder Sues, Endo Health Kisses Watson Pharma - Wall St. Cheat Sheet 05.29.12 | 11:05 am
- Auxilium-Glaxo to Drive Testim Sales - Analyst Blog - Zacks 05.22.12 | 10:05 am
- UPDATE: Citigroup Rates Endo Pharmaceuticals as Buy, $48 TP - Benzinga 03.26.12 | 12:03 pm
- BioDelivery Sciences Provides Business Review - Benzinga 03.19.12 | 04:03 pm
- VIX - Options Volatility Sonar: Friday Recap - Seeking Alpha 03.09.12 | 04:03 pm
- Earnings Beat at Endo Pharma - Analyst Blog - Zacks 02.28.12 | 09:02 am
- Stocks To Watch This Week - Seeking Alpha 01.10.12 | 08:01 am
- Billionaire David Shaw's Favorite Stock Picks - Seeking Alpha 12.15.11 | 09:12 am
- Nupathe's Zelrix Going Down A Path With Multiple Headwinds - Seeking Alpha 12.09.11 | 09:12 am
